|
0
|
|
Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018-2023.
(journals.asm.org)
|
Camelena F
…
Bercot B
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#surveillance
#infection
#sequencing
|
|
0
|
|
Adjunctive povidone-iodine for Acanthamoeba keratitis: a randomized trial.
(journals.asm.org)
|
Rajaraman R
…
Keenan JD
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#infection
#keratitis
#treatment
#amr
|
|
0
|
|
In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium.
(journals.asm.org)
|
Le Roy C
…
Pereyre S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".
(journals.asm.org)
|
Fabrizio C
…
Tascini C
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli.
(journals.asm.org)
|
Stellfox ME
…
Doi Y
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#antibiotic
|
|
0
|
|
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen Candida glabrata reveals the niche-specific requirement for FKS1 and FKS2 during infection and gut colonization.
(journals.asm.org)
|
Arastehfar A
…
Perlin DS
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#virulence
#infection
#colonization
#transcriptomics
|
|
0
|
|
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections.
(journals.asm.org)
|
Karaba SM
…
Tamma PD
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#bactericidal
|
|
0
|
|
Ceftazidime-avibactam resistance evolution in Pseudomonas aeruginosa and implications for cross-resistance to other novel beta-lactams.
(journals.asm.org)
|
Dorazio AJ
…
Shields RK
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
|
|
0
|
|
Prevalence and genetics of cefepime resistance among the AmpC-producing organisms Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes.
(journals.asm.org)
|
Schrader SM
…
Pecora ND
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#genomics
#infection
|
|
0
|
|
Targeting the disease response with NlpD and LytM for effective non-antibiotic treatment of urinary tract infections.
(academic.oup.com)
|
Tran HT
…
Ambite I
Journal of Infectious Diseases
2026-05-06
|
#infection
#immunity
#transcriptomics
#virulence
|
|
0
|
|
Hydrogen cyanide generation by Pseudomonas aeruginosa blunts the host innate immune response.
(academic.oup.com)
|
Szabo C
…
Nordmann P
Journal of Infectious Diseases
2026-05-06
|
#virulence
#immunity
#infection
#pathogenesis
|
|
0
|
|
Host plasma protein biomarkers for tuberculosis disease screening in febrile adults in Tanzania.
(academic.oup.com)
|
Prodanuk M
…
Richard-Greenblatt M
Journal of Infectious Diseases
2026-05-06
|
#diagnostics
#immunity
#infection
#biomarker
#tb
|
|
0
|
|
Identification and characteristics of a novel fosfomycin glutathione transferase, FosA12, from an MDR clinical isolate of Proteus vulgaris.
(journals.asm.org)
|
Lu W
…
Wu S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.
(journals.asm.org)
|
Vetter P
…
Neofytos D
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#influenza
#antiviral
#immunocompromised
#infection
#amr
|
|
0
|
|
Single point mutations in global regulatory genes restore cephalosporin resistance in a low-MIC Enterococcus faecium natural isolate.
(journals.asm.org)
|
Sanchez-Osuna M
…
Pich OQ
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#mutation
#transcriptomics
#infection
|
|
0
|
|
Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.
(journals.asm.org)
|
Singh S
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#pharmacokinetics
#infection
#amr
#tb
|
|
0
|
|
Human Dectin-1- and Dectin-2-targeted DectiSomes are effective against diverse pathogenic fungi.
(journals.asm.org)
|
Ambati S
…
Meagher RB
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#antifungal
#infection
#immunity
#drug delivery
|
|
0
|
|
Safety and efficacy of echinocandin antifungal agents in Candida albicans endophthalmitis.
(journals.asm.org)
|
Zhang Y
…
Wu H
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#antifungal
#infection
#biofilm
#toxicity
|
|
0
|
|
HIV-1 signalling remodels nuclear pores to licence infection.
(nature.com)
|
Mesner D
…
Jolly C
Nature
2026-05-06
|
#infection
#signaling
#nuclear import
#hiv
#virus
|
|
0
|
|
Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum.
(journals.asm.org)
|
Poonawala H
…
Aldridge BB
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#susceptibility
#amr
#mycobacteria
#infection
#mic
|
|
0
|
|
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.
(linkinghub.elsevier.com)
|
Cossa M
…
Garcia-Basteiro AL
Lancet Infectious Diseases
2026-05-06
|
#tb
#hiv
#diagnosis
#infection
#screening
|
|
0
|
|
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli.
(journals.asm.org)
|
Shropshire WC
…
Shelburne S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#genomics
#plasmid
#infection
#sequencing
|
|
0
|
|
RNA Polymerase 1 inhibitors against African trypanosomes in vitro and in mice.
(journals.asm.org)
|
Cumming AV
…
Shapiro TA
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#parasite
#trypanosomiasis
#drug development
#transcription
#infection
|
|
0
|
|
Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-beta-lactamase-producing Enterobacterales isolated in 2024 in France.
(journals.asm.org)
|
Emeraud C
…
Dortet L
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#antibiotic
#susceptibility
|